Dr. Tilman Schneider-Hohendorf
Dr. Tilman Schneider-Hohendorf
University of Muenster, Neurology
Verified email at ukmuenster.de - Homepage
Cited by
Cited by
L-selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients
N Schwab, T Schneider-Hohendorf, V Posevitz, J Breuer, K Göbel, ...
Neurology 81 (10), 865-871, 2013
Ultraviolet B light attenuates the systemic immune response in central nervous system autoimmunity
J Breuer, N Schwab, T Schneider‐Hohendorf, M Marziniak, H Mohan, ...
Annals of neurology 75 (5), 739-758, 2014
VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells
T Schneider-Hohendorf, J Rossaint, H Mohan, D Böning, J Breuer, ...
Journal of Experimental Medicine 211 (9), 1833-1846, 2014
Fatal PML associated with efalizumab therapy: insights into integrin αLβ2 in JC virus control
N Schwab, JC Ulzheimer, RJ Fox, T Schneider-Hohendorf, BC Kieseier, ...
Neurology 78 (7), 458-467, 2012
Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation
CC Gross, A Schulte-Mecklenbeck, A Rünzi, T Kuhlmann, ...
Proceedings of the National Academy of Sciences 113 (21), E2973-E2982, 2016
CD4+ T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients
D Dubinski, J Wölfer, M Hasselblatt, T Schneider-Hohendorf, U Bogdahn, ...
Neuro-oncology 18 (6), 807-818, 2016
CD8+ T-cell immunity in chronic inflammatory demyelinating polyradiculoneuropathy
T Schneider-Hohendorf, N Schwab, N Üçeyler, K Göbel, C Sommer, ...
Neurology 78 (6), 402-408, 2012
Natalizumab-associated PML: challenges with incidence, resulting risk, and risk stratification
N Schwab, T Schneider-Hohendorf, N Melzer, G Cutter, H Wiendl
Neurology 88 (12), 1197-1205, 2017
Effects on capacitance by overexpression of membrane proteins
D Zimmermann, A Zhou, M Kiesel, K Feldbauer, U Terpitz, W Haase, ...
Biochemical and biophysical research communications 369 (4), 1022-1026, 2008
Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking
K Göbel, S Pankratz, T Schneider-Hohendorf, S Bittner, MK Schuhmann, ...
Journal of autoimmunity 36 (2), 106-114, 2011
Regulatory T cells exhibit enhanced migratory characteristics, a feature impaired in patients with multiple sclerosis
T Schneider‐Hohendorf, MP Stenner, C Weidenfeller, AL Zozulya, ...
European journal of immunology 40 (12), 3581-3590, 2010
Therapy with natalizumab is associated with high JCV seroconversion and rising JCV index values
N Schwab, T Schneider-Hohendorf, B Pignolet, J Breuer, CC Gross, ...
Neurology-Neuroimmunology Neuroinflammation 3 (1), 2016
PML risk stratification using anti-JCV antibody index and L-selectin
N Schwab, T Schneider-Hohendorf, B Pignolet, M Spadaro, D Görlich, ...
Multiple Sclerosis Journal 22 (8), 1048-1060, 2016
CD8+ T-cell pathogenicity in Rasmussen encephalitis elucidated by large-scale T-cell receptor sequencing
T Schneider-Hohendorf, H Mohan, CG Bien, J Breuer, A Becker, D Görlich, ...
Nature communications 7 (1), 1-14, 2016
Therapeutic uses of anti-α4-integrin (anti-VLA-4) antibodies in multiple sclerosis
N Schwab, T Schneider-Hohendorf, H Wiendl
International immunology 27 (1), 47-53, 2015
Volume regulation of murine T lymphocytes relies on voltage-dependent and two-pore domain potassium channels
N Bobak, S Bittner, J Andronic, S Hartmann, F Mühlpfordt, ...
Biochimica et Biophysica Acta (BBA)-Biomembranes 1808 (8), 2036-2044, 2011
Teriflunomide treatment for multiple sclerosis modulates T cell mitochondrial respiration with affinity-dependent effects
L Klotz, M Eschborn, M Lindner, M Liebmann, M Herold, C Janoschka, ...
Science Translational Medicine 11 (490), 2019
Immunological and clinical consequences of treating a patient with natalizumab
N Schwab, KG Höhn, T Schneider-Hohendorf, I Metz, MP Stenner, S Jilek, ...
Multiple Sclerosis Journal 18 (3), 335-344, 2012
Neurocognitive decline in HIV patients is associated with ongoing T‐cell activation in the cerebrospinal fluid
OM Grauer, D Reichelt, U Grüneberg, H Lohmann, ...
Annals of clinical and translational neurology 2 (9), 906-919, 2015
CD8+ T cell-mediated endotheliopathy is a targetable mechanism of neuro-inflammation in Susac syndrome
CC Gross, C Meyer, U Bhatia, L Yshii, I Kleffner, J Bauer, AR Tröscher, ...
Nature communications 10 (1), 1-19, 2019
The system can't perform the operation now. Try again later.
Articles 1–20